BORIS (CTCFL) is the paralog of CTCF (CCCTC-binding factor; NM_006565), a ubiquitously expressed DNA-binding protein with diverse roles in gene expression and chromatin organisation. BORIS and CTCF have virtually identical zinc finger domains, yet display major differences in their respective C-and N-terminal regions. Unlike CTCF, BORIS expression has been reported only in the testis and certain malignancies, leading to its classification as a ''cancer-testis'' antigen. However, the expression pattern of BORIS is both a significant and unresolved question in the field of DNA binding proteins. Here, we identify BORIS in the cytoplasm and nucleus of a wide range of normal and cancer cells. We compare the localization of CTCF and BORIS in the nucleus and demonstrate enrichment of BORIS within the nucleolus, inside the nucleolin core structure and adjacent to fibrillarin in the dense fibrillar component. In contrast, CTCF is not enriched in the nucleolus. Live imaging of cells transiently transfected with GFP tagged BORIS confirmed the nucleolar accumulation of BORIS. While BORIS transcript levels are low compared to CTCF, its protein levels are readily detectable. These findings show that BORIS expression is more widespread than previously believed, and suggest a role for BORIS in nucleolar function.
Introduction
CTCFL or BORIS (Brother of the Regulator of Imprinted Sites), a paralog of CTCF, has been classified as a cancer-testis antigen as its distribution is reported to be limited to the testis and certain cancers [1] . Abnormally high levels of BORIS transcripts are present in a variety of human tumours and cancer-derived cell lines and, in some, increased expression has been linked to promoter-specific demethylation and de-repression of co-expressed cancer-testis genes [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12] . Different studies have reported contradictory findings of BORIS expression in some types of cancer. For example, a reported increased expression in several breast cancer cell lines and in the majority of primary breast tumours tested in one study was not confirmed by another [3, 13] . Furthermore, increased transcription levels of BORIS have been found in melanoma cell lines but not in primary melanomas [7] . Nevertheless, the importance of BORIS in cancer is suggested by the finding of high levels in advanced epithelial ovarian cancer [14] .
BORIS and CTCF genes are thought to have evolved during vertebrate development from a gene duplication event [15] . Whilst the zinc finger domains that bind DNA in the respective proteins are very similar, the C-and N-terminal domains of BORIS exhibit no significant homology with CTCF or any other proteins [16] . BORIS does not contain the modular substrates for specific post-translational modifications that are critical for CTCF function and lacks the conserved C-terminal phosphorylation motif required for CTCF-mediated growth suppression. This would suggest different functions for the two proteins.
Several lines of evidence point to a role for BORIS in epigenetic regulation of gene expression. During mouse male germ-line development, BORIS is observed in primary spermatocytes but is progressively replaced by CTCF in post-meiotic germ-line cells [17] . This switch in expression from BORIS to CTCF coincides with the re-establishment of site-specific DNA-methylation patterns during male germ cell differentiation [17] . Furthermore, in tumour cell lines where CTCF silences genes by DNA methylation, conditional expression of BORIS leads to replacement of CTCF by BORIS at these genes, resulting in local demethylation and gene activation [6, 10, 11, 18] .
The DNA binding and epigenetic functions attributed to BORIS would suggest a nuclear localization. However, recent reports show BORIS present mainly in the cytoplasm of prostate epithelia, testis and prostate cancer cell lines [1] while nuclear localization is only identified at specific stages of spermatogenesis and in some 5-aza-dexoxycytidine-treated prostate cancer cell lines [5] . Here, we show predominant localization of BORIS within the nucleolus in several cancer cell lines and primary cells, with enrichment within the nucleolin core structure and adjacent to fibrillarin in the dense fibrillar component.
Results and Discussion

BORIS expression in normal and cancer cells and tissues
To determine the level of BORIS expression in normal human tissues, total RNA was obtained from human adipose, bladder, brain, cervix, colon, esophagus, kidney, liver, ovary, placenta, prostate, skeletal muscle, small intestine, spleen, testis, thymus, thyroid and trachea (Ambion). Real-time RT-PCR showed the highest BORIS transcript levels in the testis (10 10 transcripts/mg total RNA), while lower levels were detected in the other tissues (10 5 -10 8 transcripts/mg total RNA) in agreement with other reports [7] (Fig. 1) . We did not detect BORIS in heart or lung, although this may be due to a limitation in the sensitivity of our assay. CTCF transcript levels were relatively constant in all tissues (10 9 -10 10 transcripts/mg total RNA) (Fig 1) . Next, we compared transcript levels of BORIS and CTCF in a variety of normal and cancer cell lines. Real-time RT-PCR analysis showed similar levels of BORIS and CTCF mRNA in fibroblasts, embryonic kidney cells, neural stem cells, neurons, colorectal, prostate, medulloblastoma, glioblastoma, melanoma and neuroblastoma cell lines to those observed in human tissues. BORIS expression was lower (10 6 -10 7 transcripts/mg total RNA), compared to the more abundant CTCF (10 9 -10 10 transcripts/mg total RNA) ( Fig. 2A) . Hence, BORIS and CTCF are present in both normal and cancer cells, with expression of CTCF often 1000 fold greater.
Unexpectedly, Western blotting showed similar levels of BORIS expression in normal and tumour cell lines (Fig. 2B ). We identified strong major bands of 60-70 kDa in agreement with the theoretical molecular weight of BORIS [19] . We also detected some lower and higher molecular weight bands. It is not yet clear which of these bands corresponds to the recently described isoforms of BORIS [19] or which are BORIS with posttranslational modifications. However, incubating the BORIS antibody with BORIS peptide completely blocked all bands (Fig.  S1 ). None of these BORIS reactive bands were detected when the membranes were probed with CTCF antibodies (Fig. 2C) .
To confirm the specificity of the BORIS antibody, HEK293T cells were transfected with GFP-tagged BORIS, or GFP-tagged CTCF constructs. Western analysis confirmed the presence of BORIS protein in cells transfected with GFP-tagged BORIS, whilst only endogenous BORIS was detected in untransfected cells or cells transfected with GFP-CTCF or empty vector (Fig. S2) .
We then used real-time RT-PCR to determine the levels of BORIS expression in normal mouse tissues including cerebellum, gut, kidney, liver, ovary, spleen and testis. As in human tissues, we found a far lower level of BORIS compared to CTCF in mouse tissues with the exception of the testis (Fig. 3A) . Western blotting on a selection of mouse tissues revealed several bands, the most abundant of which were at 60-70 kDa (Fig. 3B) . We also detected a band of approximately 48 kDa in the kidney, hippocampus, gut and the cortex, whilst other less intense bands above 200 kDa were present in the testis, spleen, lungs and the liver (Fig. 3B) . These higher molecular weight bands may correspond to homo/ heterodimer of BORIS, or poly(ADP)-ribosylation as has been described for CTCF [20] . Again, no bands were detected when membranes were probed with BORIS antibodies pre-incubated with free BORIS peptides (Fig. S3) , neither did we detect the same bands when membranes were probed with CTCF antibodies (Fig. 3C ). Although BORIS protein is clearly detectable, we only detect low levels of BORIS transcripts, both in cells and tissues (Fig 1, Fig 2A and Fig 3A) . However, discordance between mRNA level and protein abundance has been reported to be poor for certain other genes [21, 22, 23] .
In view of the similarity in their zinc finger domains, BORIS has been suggested to be an antagonist, competitor or regulator of CTCF in germ cells and human cancers [17] . Indeed, BORIS and CTCF do compete for binding to common DNA targets. For example, CTCF occupancy at the MAGE-A1 promoter only occurs if BORIS expression levels are low [11] . As the N-and Cterminal ends of BORIS and CTCF are different, they are likely to be responsible for different functional outcomes, such as mediating DNA demethylation, after binding to DNA. The relative levels of BORIS and CTCF are thus likely to be crucial for maintaining stability in normal gene expression profiles.
Nucleolar localization of BORIS
Immunofluorescence staining showed that BORIS is located within the cytoplasm and the nucleus of several human cell types, including MRC5 fibroblast, HEK293T embyonic kidney cells, neural stem cells, colorectal, neuroblastoma, melanoma, prostate and glioblastoma cell lines. In all cell types examined, BORIS immunoreactivity was enriched in the nucleolus (Fig. 4 and Fig. S4 ). Overnight incubation of BORIS antibody with the peptide completely blocked the immunofluorescent signal further confirming the specificity of the BORIS antibodies (Fig. S5) . No immunoreactivity was detected when cells were stained with nonspecific IgG antibodies. Co-staining of cells for BORIS or CTCF and fibrillarin, a highly conserved protein that is associated with small nucleolar RNAs [24] , confirmed enrichment of BORIS but not CTCF in the nucleolus (Fig. 4A,B) . Further co-staining showed BORIS within the nucleolar space occupied by nucleolin, an abundant non-ribosomal nucleolar protein [25] (Fig. 4C ). Confocal microscopy and 3D reconstruction confirmed that BORIS was within the nucleolus, adjacent to fibrillarin in both normal and cancer cells (Fig. 5A , B and Movies S1, S2, S3 and S4).
To confirm these findings, HEK293T cells were transfected with GFP-tagged BORIS or GFP-tagged CTCF constructs. Using live-cell imaging, GFP was found to accumulate progressively in nucleoli of cells transfected with GFP-BORIS. 71.3% +/2 1.7 of GFP-BORIS transfected cells showed clear nucleolar localization (873 cells analysed in total from two independent experiments). In contrast, cells transfected with GFP-CTCF showed an even distribution of GFP throughout the nucleus, and those cells transfected with an empty GFP vector showed mainly GFP in the cytoplasm (Fig. 6 ). Furthermore, immunostaining of cells 72 hours after transfection of HEK293T cells with BORIS specific shRNA plasmids, but not empty vector, significantly (p,0.05) reduced the nucleolar immunostaining of BORIS (Fig. S6A, B ). This was accompanied by a corresponding reduction in BORIS transcript levels ( Fig S7) .
Putative Nucleolar Localization Sequences
Computational analysis of the BORIS protein sequence Q8NI51, [26] , revealed 2 putative nucleolar localization sequences in the zinc finger domain: These sequences would support the finding of BORIS in the nucleolus as well as the translocation of CTCF into the nucleus during differentiation of human hematopoietic cells [27] .
UBF (upstream binding factor) has been recently identified as the first common interaction partner of BORIS and CTCF [28] . This interaction was shown to be direct and to require the zinc finger domains of BORIS and CTCF, the high mobility group (HMG)-box 1, and the dimerization domain of UBF. CTCF was found to bind immediately upstream of the ribosome spacer promoter in a methylation-sensitive manner, where it is suggested to load UBF onto rDNA to form part of a network that maintains rDNA genes poised for transcription. Our immunofluorescence staining did not show enrichment of CTCF in the nucleolus, however, low levels of CTCF may be present but below detection in our assay. Torrano et al., demonstrated that the translocation of CTCF to the nucleolus after induction of differentiation in human and rat cells was regulated by poly(ADP-ribosyl)ation [27] . UBF is very abundant in the nucleolus and has been shown to be highly dynamic [29] . Thus, the direct interaction between CTCF and UBF may be transient and, since BORIS recognizes the same DNA binding sites [1] , there may be competition between CTCF and BORIS to bind UBF [22] . Taken together with the findings described here, the direct interaction of BORIS with UBF suggests BORIS plays an important role in ribosome biogenesis.
Concluding remarks
This is the first report showing BORIS localising predominantly in the nucleolus in many different malignant and non-malignant cell types. The nucleolus is a multi-functional sub-nuclear compartment where for example, ribosomal RNAs are synthesized, processed and assembled with ribosomal proteins [30, 31, 32] . However, extensive proteomic analysis has revealed the dynamic nature of the nucleolar proteome and suggests that the nucleolus may perform many other biological roles in addition to ribosome biogenesis such as the regulation of specific aspects of mitosis and cell cycle progression [24, 33, 34 ]. Here we demonstrate that BORIS is clearly more than a testis-specific protein, and show a distinct subcellular localization in multiple cell lines as well as normal human and mouse tissues. BORIS is enriched in the nucleolus, inside nucleolin core structure and adjacent to fibrillarin. Our novel finding of widespread expression of BORIS together with its nucleolar localization warrants further investigation to ascertain its precise function in this context.
Materials and Methods
Cell Culture
Cancer cell lines were maintained in RPMI or DMEM supplemented with 10% fetal bovine serum (unless stated otherwise), 100-units/ml penicillin, 100-mg/ml streptomycin, and 
Tissue protein isolation
Mouse tissues were isolated from 3-month-old C57bl6 or NOD mice and snap frozen in liquid nitrogen. All experimental protocols involving mouse tissues were approved by the Home Office Animal Procedures Committee, under the project license number PPL 70/6693. Tissues were disrupted in Qiagen RLT lysis buffer for RNA extraction, or into 1X RIPA buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% Na Deoxycholate, 0.1% SDS) containing protease inhibitors (Protease Inhibitor Cocktail Set III EDTA-free, Calbiochem) and phosphatase inhibitors (Phosphatase Inhibitor Cocktail Set II, Calbiochem) for protein analysis. Total protein lysates were prepared from 10 8 cells in 1X RIPA buffer. Lysed cells were sonicated briefly with a Bioruptor and debris cleared by centrifugation. The protein content of the extracts was estimated using BCA kit (Thermo Fisher Scientific) according to the manufacturer's protocol.
RNA Isolation and Reverse Transcription
Total RNA was isolated using silica-based spin-column extraction kit (RNeasy mini kit, Qiagen) following the manufacturer's protocol. Total RNA was treated with RNase-free DNase1 (Ambion) to reduce genomic DNA contamination. RNA integrity was evaluated using the Agilent Bioanalyzer. Two micrograms of total RNA was reverse transcribed with SuperScriptase III (Invitrogen) using Oligo-dT primers or random hexamers according to the manufacturer's protocol. Negative (-RT) controls contained RNase-free water substituted for reverse transcriptase.
Quantitative Real-Time PCR
Both the published primers [3] and our own designed with Primer Express 2.0 were used in this study. Together these primers amplify 19 out of the 23 isoforms of BORIS described recently [19] . Human primers were as follows:
BORIS exon 4-5 forward: mRNA levels were quantified on an ABI7500 instrument using SYBR Green JumpStart Taq ReadyMix kit (Sigma-Aldrich) or platinium Taq polymerase kit (Invitrogen) with 50-100 ng of cDNA (except for BORIS primers when 150-200 ng of cDNA was used) and 100-200 nM primers. We used primers spanning the exon 4/5 junction of BORIS and findings were confirmed using published primers to exon 6/7 [2, 3] , and exon 9/10 [13] in a qRT-PCR assay with various concentrations of total cellular RNA. Absolute concentrations were estimated using standard curves generated from serial dilution of amplicons. The threshold cycle from serial dilutions of single stranded oligonucleotides was plotted against the log copy numbers of the target PCR products, and reported as copy numbers/mg of total RNA [35] .
Western Blot Analysis
20-50 mg of protein extract and 10 ul of molecular weight standard (Invitrogen NovexHSharp Pre-Stained Protein Standard, LC5800 or GE Healthcare Full Range Rainbow Marker, RPN800E) were separated on a 4-12% gradient NuPAGE polyacrylamide gel (Invitrogen) and then blotted onto nitrocelluose membrane (Invitrogen) according to the manufacturer's protocol. The nitrocellulose membrane was incubated in Tris-buffered saline blocking solution containing 5% skimmed milk and 0.1% Tween-20. The membrane was then probed with primary antibodies using standard conditions. We selected two antibodies against BORIS; a rabbit polyclonal antibody ab18377 (Abcam), raised against a synthetic peptide within the first 100 amino acids, and a rabbit polyclonal antibody HPA001472 (Sigma), raised against amino acids 33-172. These commercially available antibodies should recognize most of the 23 isoforms of BORIS and have been characterized previously [13, 28] . BORIS antibody ab18337 (1:1000 dilution, Abcam) was used for all Western data shown and BORIS antibody HPA001472 (1:200 dilution, Sigma) was used to confirm the bands (data not shown). For CTCF, we used antibody 07-729 (1:1000 dilution, Millipore) and for GAPDH we used antibody 14C10 (1:2000 dilution, Cell Signalling). After several washes, bands were revealed with the corresponding horseradish peroxidase coupled secondary antibody and detected using the ECL detection kit (GE Healthcare) according to the manufacturer's protocol.
Immunofluorescence
Cells were grown on coverslips and fixed with 4% paraformaldehyde (Electron Microscopy Sciences) in phosphate-buffered saline, 0.14 M NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4, pH 7.2-7.4 for 10 minutes at room temperature, followed by permeabilization in blocking buffer (phosphatebuffered saline containing 0.1% Triton X-100, 0.01% saponin and 10% goat serum) for 30 minutes at room temperature. Cells were then incubated with the specific antibodies in blocking buffer overnight at 4uC. BORIS antibody ab18337 (1:100 dilution, Abcam) was used for all standard imaging. BORIS antibody HPA001472 (1:25 dilution, Sigma) was used for confocal imaging and movies. Staining with both antibodies showed identical localization. We used CTCF antibody 07-729 (1:1000 dilution, Millipore), Nucleolin (C23) antibody sc-8031 (1:1000 dilution, Santa Cruz Biotechnology) and Fibrillarin antibody ab18380 (1:1000 dilution, Abcam). Cells were washed in PBS, and primary immunoreactions visualized after incubation for 1 hour at room temperature with the Alexa Fluor 594 chicken anti-mouse IgG, A-21201 and Alexa Fluor 488 chicken anti-rabbit IgG, A-21441 (both Invitrogen). Nuclei were counterstained with 0.1 mg/ml 49, 6-Diamidino-2-phenylindole (DAPI, Molecular Probes) and coverslips were mounted in Mowiol (Calbiochem). For standard 2 dimensional analysis specimens were visualized using a Zeiss Axiophot microscope equipped for epifluorescence using Zeiss plan-neofluar 20x, 40x or 100x objectives. Separate grey-scale images were recorded with a cooled CCD-camera (Hamamatsu, Welwyn Garden City, UK). Image analysis was performed using SmartCapture X software (Digital Scientific, Cambridge, UK).
For 3 dimensional analysis specimens were studied using a Zeiss Meta 510 LSM using a 63x objective. Deconvolution of images was performed using Huygens Essential software and images then processed in Imaris x64 (v7.1.1).
Peptide Competition
Antibody specificity was assessed using a specific blocking peptide ab22203 (Abcam). 20 ug peptide was added to 10 ug BORIS antibody ab18337 (Abcam) in 200 ul TBST buffer and incubated at 37uC overnight. Both blocked and unblocked antibody was diluted 1:10 in blocking buffer for immunofluorescence. All images for both blocked and unblocked antibody were collected using the same exposure times. BORIS antibody specificity was also assessed by performing Western blotting with peptide blocked antibody diluted 1:100 in blocking solution containing 2 ug/ml blocking peptide. Control unblocked antibody was incubated at the same time in appropriate blocking buffer without the addition of blocking peptide.
Cloning and Transfection
Recombinant constructs GFP-BORIS or GFP-CTCF, were prepared by inserting BORIS or CTCF cDNA into pEGFP-C3 vector (Clontech). Fragments encoding full length BORIS (1-663aa) and CTCF (1-727) were generated by PCR using the following primers:
BORIS-GFP forward: 59-CGGAATTCTGATGGCAGCCACTGAGATCTCTGTC-39 and reverse: 59-GCGGGATCCTCACTTATCCATCGTGT-TGAGGAGC-39 CTCF-GFP forward: 59-CGGAATTCTGATGGAAGGTGATGCAGTCGAAGCC-39 and reverse: 59-GCGGGATCCTCACCGGTCCATCATGC-TGAGAGGATC-39 and pCMV6-XL5-BORIS or pCMV6-XL5-CTCF plasmids (Origene) as templates, respectively.
PCR fragments were digested with EcoRI/BamHI inserted into the pEGFP-C3 MCS in-frame of EGFP. Each construct was confirmed by sequencing. The resulting GFP-BORIS, GFP-CTCF and pEGFP-C3 vectors were transfected into HEK293T cells using FuGene 6-HD (Roche) according to manufacturer's protocol. Live transfected cells plated onto glass coverslips were stained with Hoechst 333412 (Invitrogen) and imaged 48 hours after transfection. For Western analysis, three million cells were transfected using FuGene 6-HD (Roche) and cells collected for protein extraction 72 hours later.
shRNA mediated knockdown of BORIS HEK293T cells were transiently transfected using purified and sequence verified plasmids: GI320730 (targeted to a BORIS specific site encoded by Exon 5 which is included in 19/23 splice variants identified by Pugacheva et al., [19] ), GI320731 (targeted to a BORIS specific site encoded by Exon 3 which is present in all 23 variants), TR30007 (empty pGFP-V-RS vector) and TR30008 (29-mer Non-Effective GFP (pGFP-V-RS)) from Origene (kit catalogue number TG305184). Briefly, HEK293T cells were transfected with shRNA clones GI320730, GI320731, TR30008 or TR30007 using FuGene 6-HD (Roche). Cells were analysed 72 hours after transfection. Three biological replicate shRNA experiments were performed for each shRNA clone. Quantification of mRNA transcripts was performed using RT-PCR and all data normalized to GAPDH and empty vector set to 1. For quantification of BORIS immunofluorescence staining, images of HEK293T cells were collected 72 hours after transfection using the same exposure time. Images captured from 5 random fields containing at least 30 cells were imported into ImageJ software version 1.44 (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/). Regions of interest (ROI) were created as a mask around DAPI stained nuclei (blue) and the threshold adjusted to remove background. Fluorescence intensity was calculated for BORIS Alexa 594 signal (red) within this mask and mean nuclear fluorescence was calculated by dividing the total intensity by nuclear area in each image. Data were exported into Excel and statistical significance was assessed by One-Way Anova analysis. Movie S1 MRC5 fibroblast nucleus stained with BORIS in green (Alexa 488) and fibrillarin in red (Alexa 594), with 49, 6-Diamidino-2-phenylindole (DAPI) counterstaining in blue. BORIS immunoreactivity is enriched in the nucleolus adjacent to fibrillarin. Optical sections were obtained by confocal microscopy using a Zeiss Meta 510 LSM, and threedimensional reconstruction performed using Imaris x64 (v7.1.1). Images are shown at 63x magnification.
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Movie S2 MRC5 fibroblast nucleus stained with BORIS in green (Alexa 488) and fibrillarin in red (Alexa 594), with 49, 6-Diamidino-2-phenylindole (DAPI) counterstaining in blue. BORIS immunoreactivity is enriched in the nucleolus adjacent to fibrillarin. Optical sections were obtained by confocal microscopy using a Zeiss Meta 510 LSM, and threedimensional reconstruction performed using Imaris x64 (v7.1.1). Surface reconstruction of each channel was performed with colour properties and transparency adjusted to show spatial distribution of BORIS with respect to fibrillarin in the nucleolus. Images are shown at 63x magnification. (AVI)
Movie S3 Nucleus from a colorectal cell line, C99, stained with BORIS in green (Alexa 488) and fibrillarin in red (Alexa 594), with 49, 6-Diamidino-2-phenylindole (DAPI) counterstaining in blue. BORIS immunoreactivity is enriched in the nucleolus adjacent to fibrillarin. Optical sections were obtained by confocal microscopy using a Zeiss Meta 510 LSM and three-dimensional reconstruction performed using Imaris x64 (v7.1.1). Images are shown at 63x magnification. (AVI)
Movie S4 Nucleus from a colorectal cell line, C99, stained with BORIS in green (Alexa 488) and fibrillarin in red (Alexa 594), with 49, 6-Diamidino-2-phenylindole (DAPI) counterstaining in blue. BORIS immunoreactivity is enriched in the nucleolus adjacent to fibrillarin. Optical sections were obtained by confocal microscopy using a Zeiss Meta 510 LSM and three-dimensional reconstruction performed using Imaris x64 (v7.1.1). Surface reconstruction of each channel was performed with colour properties and transparency adjusted to show spatial distribution of BORIS with respect to fibrillarin in the nucleolus. Images are shown at 63x magnification. (AVI)
